Abstract:Hydantoins, a class of five-membered heterocyclic compounds, exhibit diverse biological activities. The aim of this study was to synthesize and characterize a series of novel 3,5-disubstituted hydantoins and to investigate their antiproliferative activity against human cancer cell lines. The new hydantoin derivatives 5a‒i were prepared as racemic mixtures of syn- and anti-isomers via a base-assisted intramolecular amidolysis of C-3 functionalized β-lactams. The enantiomers of syn-5a and anti-hydantoins 5b were separated by preparative high-performance liquid chromatography (HPLC) using n-hexane/2-propanol (90/10, v/v) as the mobile phase. The absolute configuration of the four allyl hydantoin enantiomers 5a was assigned based on a comparison of the experimental electronic circular dichroism (ECD) and vibrational circular dichroism (VCD) spectra with those calculated using density functional theory (DFT). The antiproliferative activity evaluated in vitro against three different human cancer cell lines: HepG2 (liver hepatocellular carcinoma), A2780 (ovarian carcinoma), and MCF7 (breast adenocarcinoma), and on the non-tumor cell line HFF1 (normal human foreskin fibroblasts) using the MTT cell proliferation assay. In silico drug-like properties and ADMET profiles were estimated using the ADMET Predictor ver. 9.5 and the online server admetSAR. Eighteen new 3,5-disubstituted hydantoins were synthesized and characterized. The compound anti-5c showed potent cytotoxic activity against the human tumor cell line MCF7 (IC50 = 4.5 μmol/L) and the non-tumor cell line HFF1 (IC50 = 12.0 μmol/L). In silico analyzes revealed that the compounds exhibited moderate water solubility and membrane permeability and are likely substrates for CYP3A4 and P-glycoprotein and have a high probability of antiarthritic activity.

Synthesis of hydantoins from N‐Boc protected amino acid derived amides using polymer‐supported PPh3/CBr4 as a reagent

Synthesis of Α-Hydroxy Amides

Synthesis of Amides-Substituted 2H-Benzopyrans Through Palladium-Catalyzed One-Pot Aminocarbonylation Reaction with Nitro Compounds As the Nitrogen Sources

[4+2]-Cycloaddition to 5-Methylidene-Hydantoins and 5-Methylidene-2-Thiohydantoins in the Synthesis of Spiro-2-Chalcogenimidazolones

Synthesis, Absolute Configuration, Biological Profile and Antiproliferative Activity of New 3,5-Disubstituted Hydantoins

Regiospecific synthesis of N,N'-disubstituted-2-imino-hydantoins derived from cyanamides

An Efficient Synthesis of Hydantoins Via Sustainable Integration of Coupled Domino Processes

ChemInform Abstract: Synthesis of Highly Substituted Imidazolidine‐2,4‐dione (hydantoin) Through Tf2O‐Mediated Dual Activation of Boc‐Protected Dipeptidyl Compounds.

Access to Phthalazinones Via Palladium-Catalyzed Three-Component Cycloamino-Carbonylation of 2-Formylaryl Tosylates, Hydrazines and Co

Synthesis of 1,4‐Disubstituted and 1‐Substituted β‐Carbolines via 3‐Substituted 2‐Acylindoles

Cycloadditions of 5-Vinyloxazolidine-2,4-diones: A Straightforward Access to the (Thio)hydantoin Scaffold

Bioinspired Synthesis of Nitriles from Primary Amides via Zinc/Anhydride Catalysis

Efficient Synthesis of Nitrile Compounds Through Amide Conversion Via N-Boroamide Intermediates

Synthesis of Chiral Hydantoins and Thiazolidinediones <i>via</i> Iridium-Catalyzed Asymmetric Hydrogenation

An SN2 Reaction at Amide Nitrogen Enables Hydrazide Synthesis

Improved synthesis of two quisqualic acid analogs containing hydantoin and imidazolidinone moieties

Synthesis and Conformational Analysis of Hydantoin-Based Universal Peptidomimetics

Parallel Synthesis of 1,6-Disubstituted-1,2,4-triazin-3-ones on Solid-Phase

Direct Access to Hydrazides and Amides from Carboxylic Acids via Acyloxyphosphonium ion

Iron-Catalyzed Oxidative C(sp3)–C(sp3) Radical Coupling Reaction between Thiohydantoins and O-Acetyloximes for the Synthesis of 1,3-Dibenzyl-3,4-dihydropyrrolo[2,3-d]imidazole-2(1H)-thione Derivatives

Versatile Synthesis of 4-Spiro-β-lactam-3-carbonitriles Via the Intramolecular Nucleophilic Cyclization of N-(p-hydroxyphenyl)cyanoacetamides